Boston, MA. (July 13, 2021) – Medcase, formerly Edgecase AI, a Boston/Israeli-based marketplace for on-demand access to expert clinicians and annotated medical data, has announced a 4.1-million USD seed financing round led by Sopris Capital, a U.S.-based venture capital firm. Medcase has a global marketplace of leading clinicians to power the next phase of healthcare innovation offering access to clinicians at scale while providing quality, effectiveness, and compliance to democratize healthcare globally.
“We’re delighted to have Sopris Capital join us, along with Firstime VC and Sarona VC, to help us expand the first truly global healthcare system that goes beyond conventional borders,” said Kyle Giddens, Co-Founder, and CEO of Medcase. “This capital infusion will allow Medcase to further expand our already established roster of specialized clinicians to enterprise customers and patients around the world.”
Medcase has developed a centralized hub for enterprises innovating in the healthcare, pharmaceutical, and medical technology community by offering a trustworthy network of clinicians and valued annotated medical data for businesses like hospitals, medical device manufacturers, pharmaceutical, and insurance companies regardless of international borders.
With leading innovative customers such as Google and Zebra Medical, Medcase is breaking barriers on a global scale by aggregating the collective intelligence of clinicians to change the world by making healthcare more accessible via AI and Telemedicine.
“Sopris has spent the past two decades backing talented entrepreneurs solving critical pain points in the healthcare industry,” says Jason Smith, Partner at Sopris Capital. “Medcase has achieved early product-market fit, and we are excited to partner with the Medcase management team in increasing access to quality clinicians worldwide for a variety of enterprise use cases.”
Other notable customers with medical technology leaders include Verily Life Sciences and Maccabi Healthcare Services, to name a few. Medcase provides access to extensive libraries of annotated healthcare content, clinical opinions, and surveys, while also connecting key stakeholders via live video for a variety of telemedicine and other use cases.
Prior to the latest seed round by Sopris Capital, Medcase has been self-funded and rapidly growing. Following the most recent funding, Medcase has expanded its de facto marketplace for businesses seeking to interact with clinicians in over 20 countries across 24+ specialties and 31 languages.
About medcase:
Founded in 2017, Medcase is the leading marketplace connecting global clinicians, healthcare data and enterprises innovating in healthcare. The platform connects businesses to clinicians in more than 31 languages worldwide, offering the best doctors, specialists, and clinicians. The scalable platform with API connectivity helps meet all clients’ needs while being HIPAA and Sunshine Act compliant. Learn more at: http://www.medcase.health
About Sopris Capital:
Founded in 2002, Sopris Capital is a US-based venture capital firm that invests in early-stage high-growth healthcare and B2B technology companies. Sopris seeks to be a value-added partner to emerging companies with validated business models, evidence of product/market fit, and passionate management team that can capitalize on the market opportunity. Learn more at: http://www.sopriscapital.com
About Firstime Venture Capital:
Founded in 2014, Firstime Venture Capital is a venture capital fund, investing in Pre A & A rounds, in cutting-edge, disruptive technologies, based on state-of-the-art ideas and headed by brilliant people. Firstime VC invests in 'digital life technologies' companies with a POC and initial customer base and provide them with the funding they need to peacefully strive to a product-market fit and generate initial revenues. This brings them to a solid KPIs achievement before seeking a proper A round. Learn more at: https://www.firstime.vc/
